Maternal anti-protein Z antibodies in pregnancies complicated by pre-eclampsia, SGA and fetal death

References

• Rezaie A R, Manithody C, Yang L. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition. J Biol Chem 2005; 280: 32722–32728
   PubMed Web of Science ®Google Scholar
• Yin Z F, Huang Z F, Cui J, Fiehler R, Lasky N, Ginsburg D, Broze G J, Jr, et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci USA 2000; 97: 6734–6738
   PubMed Web of Science ®Google Scholar
• Han X, Fiehler R, Broze G J, Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250–9255
   PubMed Web of Science ®Google Scholar
• Han X, Huang Z F, Fiehler R, Broze G J, Jr. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 1999; 38: 11073–11078
   PubMed Web of Science ®Google Scholar
• Han X, Fiehler R, Broze G J, Jr. Characterization of the protein Z-dependent protease inhibitor. Blood 2000; 96: 3049–3055
   PubMed Web of Science ®Google Scholar
• Quack Loetscher K C, Stiller R, Roos M, Zimmermann R. Protein Z in normal pregnancy. Thromb Haemost 2005; 93: 706–709
   PubMed Web of Science ®Google Scholar
• Paidas M J, Ku D H, Lee M J, Manish S, Thurston A, Lockwood C J, Arkel Y S. Protein Z. Protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 2005; 3: 497–501
   PubMed Web of Science ®Google Scholar
• Erez O, Hoppensteadt D, Romero R, Espinoza J, Goncalves L, Nien J K, Kusanovic J P, Fareed J, Gotsch F, Pineles B, et al. Pre-eclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med 2007; 20: 661–667
   PubMed Web of Science ®Google Scholar
• Kusanovic J P, Espinoza J, Romero R, Hoppensteadt D, Nien J K, Kim C J, Kim C J, Erez O, Soto E, Fareed J, Edwin S, et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. J Matern Fetal Neonatal Med 2007; 20: 453–463
   PubMed Web of Science ®Google Scholar
• Gris J C, Quere I, Dechaud H, Mercier E, Pincon C, Hoffet M, Vasse M, Mares P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606–2608
   PubMed Web of Science ®Google Scholar
• Bretelle F, Arnoux D, Shojai R, D'Ercole C, Sampol J, Dignat F, Camoin-Jau L. Protein Z in patients with pregnancy complications. Am J Obstet Gynecol 2005; 193: 1698–1702
   PubMed Web of Science ®Google Scholar
• Paidas M J, Ku D H, Arkel Y S, Elizabeth T, Christine F, Ben H, Ku Evelyn, Lockwood C J. Normal pregnancy is associated with the development of protein S and protein Z antibodies, independent of PS and PZ levels. Am J Obstet Gynecol 2004; 6(Supp.1)s140
   Google Scholar
• Gris J C, Amadio C, Mercier E, Lavigne-Lissalde G, Dechaud H, Hoffet M, Quere I, Amiral J, Dauzat M, Mares P. Anti-protein Z antibodies in women with pathologic pregnancies. Blood 2003; 101: 4850–4852
   PubMed Web of Science ®Google Scholar
• Gris J C, Mercier E, Quere I, Lavigne-Lissalde G, Cochery-Nouvellon E, Hoffet M, Ripart-Neveu S, Tailland M L, Dauzat M, Mares P. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695–3699
   PubMed Web of Science ®Google Scholar
• ACOG Practice Bulletin. Diagnosis and management of pre-eclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99: 159–167
   PubMed Web of Science ®Google Scholar
• Alexander G R, Himes J H, Kaufman R B, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87: 163–168
   PubMed Web of Science ®Google Scholar
• Redline R W, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation – a workshop report. Placenta 2005; 26(Suppl A)S114–S117
   PubMed Web of Science ®Google Scholar
• Steffano B, Forastiero R, Martinuzzo M, Kordich L. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2001; 12: 411–412
   PubMed Web of Science ®Google Scholar
• McColl M D, Deans A, Maclean P, Tait R C, Greer I A, Walker I D. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 2003; 120: 913–914
   PubMed Web of Science ®Google Scholar
• Forastiero R R, Martinuzzo M E, Lu L, Broze G J. Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost 2003; 1: 1764–1770
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Blank M. Autoantibodies associated with reproductive failure. Lupus 2004; 13: 643–648
   PubMed Web of Science ®Google Scholar
• Pardos-Gea J, Ordi-Ros J, Serrano S, Balada E, Nicolau I, Vilardell M. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Thromb Res 2007; 121: 727–734
   PubMed Web of Science ®Google Scholar
• Sailer T, Vormittag R, Koder S, Quehenberger P, Kaider A, Pabinger I. Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant. Thromb Res 2008; 122(2)153–160
   PubMed Web of Science ®Google Scholar
• Avrameas S. Natural autoantibodies: from ‘horror autotoxicus’ to ‘gnothi seauton’. Immunol. Today 1991; 12: 154–159
   PubMedGoogle Scholar
• Coutinho A, Kazatchkine M D, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995; 7: 812–818
   PubMed Web of Science ®Google Scholar
• Boyden S V. Natural antibodies and the immune response. Adv Immunol 1966; 5: 1–28
   PubMedGoogle Scholar
• Navin T R, Krug E C, Pearson R D. Effect of immunoglobulin M from normal human serum on Leishmania donovani promastigote agglutination, complement-mediated killing, and phagocytosis by human monocytes. Infect Immun 1989; 57: 1343–1346
   PubMed Web of Science ®Google Scholar
• Elson C J, Naysmith J D, Taylor R B. B-cell tolerance and autoimmunity. Int Rev Exp Pathol 1979; 19: 137–203
   PubMedGoogle Scholar
• Michael J G. Natural antibodies. Curr Top Microbiol Immunol 1969; 48: 43–62
   PubMedGoogle Scholar
• Kay M M, Goodman S R, Sorensen K, Whitfield C F, Wong P, Zaki L, Rudloff V. Senescent cell antigen is immunologically related to band 3. Proc Natl Acad Sci USA 1983; 80: 1631–1635
   PubMed Web of Science ®Google Scholar
• Galili U, Clark M R, Shohet S B. Excessive binding of natural anti-α-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction. J Clin Invest 1986; 77: 27–33
   PubMed Web of Science ®Google Scholar
• Hintner H, Romani N, Stanzl U, Grubauer G, Fritsch P, Lawley T J. Phagocytosis of keratin filament aggregates following opsonization with IgG-anti-keratin filament autoantibodies. J Invest Dermatol 1987; 88: 176–182
   PubMed Web of Science ®Google Scholar
• Lutz H U, Bussolino F, Flepp R, Fasler S, Stammler P, Kazatchkine M D, Arese P. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc Natl Acad Sci USA 1987; 84: 7368–7372
   PubMed Web of Science ®Google Scholar
• Grabar P. Hypothesis. Auto-antibodies and immunological theories: an analytical review. Clin Immunol Immunopathol 1975; 4: 453–466
   PubMedGoogle Scholar
• Mold C, Rodic-Polic B, Du Clos T W. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fcγ receptors. J Immunol 2002; 168: 6375–6381
   PubMed Web of Science ®Google Scholar
• Shaw P X, Horkko S, Chang M K, Curtiss L K, Palinski W, Silverman G J, Witztum J L. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105: 1731–1740
   PubMed Web of Science ®Google Scholar
• Quan C P, Berneman A, Pires R, Avrameas S, Bouvet J P. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997; 65: 3997–4004
   PubMed Web of Science ®Google Scholar
• Lacroix-Desmazes S, Kaveri S V, Mouthon L, Ayouba A, Malanchere E, Coutinho A, Kazatchkine M D. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 1998; 216: 117–137
   PubMed Web of Science ®Google Scholar
• el-Roeiy A, Myers S A, Gleicher N. The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women. Obstet Gynecol 1990; 75: 390–396
   PubMed Web of Science ®Google Scholar
• Matthiesen L S, Berg G, Ernerudh J, Skogh T. A prospective study on the occurrence of autoantibodies in low-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 1999; 83: 21–26
   PubMed Web of Science ®Google Scholar
• Farnam J, Lavastida M T, Grant J A, Reddi R C, Daniels J C. Antinuclear antibodies in the serum of normal pregnant women: a prospective study. J Allergy Clin Immunol 1984; 73: 596–599
   PubMed Web of Science ®Google Scholar
• Lockwood C J, Romero R, Feinberg R F, Clyne L P, Coster B, Hobbins J C. The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population. Am J Obstet Gynecol 1989; 161: 369–373
   PubMed Web of Science ®Google Scholar
• Pattison N S, Chamley L W, McKay E J, Liggins G C, Butler W S. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993; 100: 909–913
   PubMedGoogle Scholar
• Patton P E, Coulam C B, Bergstralh E. The prevalence of autoantibodies in pregnant and nonpregnant women. Am J Obstet Gynecol 1987; 157: 1345–1350
   PubMed Web of Science ®Google Scholar
• Wootla B, Dasgupta S, Dimitrov J D, Bayry J, Levesque H, Borg J Y, Borel-Derlon A, Rao D N, Friboulet A, Kaveri S V, et al. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia. J Immunol 2008; 180: 7714–7720
   PubMed Web of Science ®Google Scholar
• Allain J P, Croissant M P, Lerolle D, Houbouyan L, Zuzel M, Frommel D. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex. Thromb Haemost 1982; 48: 142–145
   PubMed Web of Science ®Google Scholar
• Croissant M P, Zuzel M, Allain J P. Heterogeneity of autoantibodies to factor VIII: differences in specificity for apparently distinct antigenic determinants of factor VIII coagulant protein. Blood 1983; 62: 133–140
   PubMed Web of Science ®Google Scholar
• Sultan Y, Rossi F, Kazatchkine M D. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII: C autoantibodies. Proc Natl Acad Sci USA 1987; 84: 828–831
   PubMed Web of Science ®Google Scholar
• Hart H C, Kraaijenhagen R J, Kerckhaert J A, Verdel G, Freen M, van de W A. A patient with a spontaneous factor VIII: C autoantibody: successful treatment with cyclosporine. Transplant Proc 1988; 20: 323–328
   PubMed Web of Science ®Google Scholar
• Algiman M, Dietrich G, Nydegger U E, Boieldieu D, Sultan Y, Kazatchkine M D. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci USA 1992; 89: 3795–3799
   PubMed Web of Science ®Google Scholar
• Dahlback B, Nilsson I M, Frohm B. Inhibition of platelet prothrombinase activity by a lupus anticoagulant. Blood 1983; 62: 218–225
   PubMed Web of Science ®Google Scholar
• Fleck R A, Rapaport S I, Rao L V. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512–519
   PubMed Web of Science ®Google Scholar
• Horbach D A, Derksen R H, de Groot P G. The presence of anti-β 2-glycoprotein I and anti-prothrombin antibodies and their correlations with venous and arterial thrombosis. Ann Med Interne (Paris) 1996; 147(Suppl 1)42–43
   PubMedGoogle Scholar
• Swadzba J, De Clerck L S, Stevens W J, Bridts C H, van Cotthem K A, Musial J, Jankowski M, Szczeklik A. Anticardiolipin, anti-β(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997; 24: 1710–1715
   PubMed Web of Science ®Google Scholar
• Forastiero R R, Martinuzzo M E, Cerrato G S, Kordich L C, Carreras L O. Relationship of anti β2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997; 78: 1008–1014
   PubMed Web of Science ®Google Scholar
• Bidot C J, Jy W, Horstman L L, Huisheng H, Jimenez J J, Yaniz M, Ahn Y S. Factor VII/VIIa: a new antigen in the anti-phospholipid antibody syndrome. Br J Haematol 2003; 120: 618–626
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles G J, Ruiz-Arguelles A, Perez-Romano B, Arcon-Segovia D. Protein S deficiency associated to anti-protein S antibodies in a patient with mixed connective-tissue disease and its reversal by danazol. Acta Haematol 1993; 89: 206–208
   PubMed Web of Science ®Google Scholar
• Sorice M, Arcieri P, Griggi T, Circella A, Misasi R, Lenti L, Di Nucci G D, Mariani G. Inhibition of protein S by autoantibodies in patients with acquired protein S deficiency. Thromb Haemost 1996; 75: 555–559
   PubMed Web of Science ®Google Scholar
• Erkan D, Zhang H W, Shriky R C, Merrill J T. Dual antibody reactivity to β2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus 2002; 11: 215–220
   PubMed Web of Science ®Google Scholar
• Bertolaccini M L, Sanna G, Ralhan S, Gennari L C, Merrill J T, Khamashta M A, Hughes G R. Antibodies directed to protein S in patients with systemic lupus erythematosus: prevalence and clinical significance. Thromb Haemost 2003; 90: 636–641
   PubMed Web of Science ®Google Scholar
• Mateo J, Oliver A, Borrell M, Sala N, Fontcuberta J. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism – results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost 1997; 77: 444–451
   PubMed Web of Science ®Google Scholar
• Jones J V, Eastwood B J, Jones E, James H, Mansour M. Antiphospholipid antibodies in a healthy population: methods for estimating the distribution. J Rheumatol 1995; 22: 55–61
   PubMed Web of Science ®Google Scholar
• Rand J H, Senzel L. Antiphospholipid antibodies and the antiphospholipid syndrome. Hemostasis and thrombosis basic principles and clinical practice, R W Colman, A E Clowes, S Z Goldhaber, V J Marder, J N George. Lippincott Williames & Wilkins, Philadelphia 2006; 1621–1636
   Google Scholar
• Lieby P, Poindron V, Roussi S, Klein C, Knapp A M, Garaud J C, Cerutti M, Martin T, Pasquali J L. Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack. Blood 2004; 104: 1711–1715
   PubMedGoogle Scholar
• von Dadelszen P, Watson R W, Noorwali F, Marshall J C, Parodo J, Farine D, Lye S J, Ritchie J W, Rotstein O D. Maternal neutrophil apoptosis in normal pregnancy, pre-eclampsia, and normotensive intrauterine growth restriction. Am J Obstet Gynecol 1999; 181: 408–414
   PubMed Web of Science ®Google Scholar
• Burton G J, Jauniaux E. Placental oxidative stress: from miscarriage to pre-eclampsia. J Soc Gynecol Investig 2004; 11: 342–352
   PubMedGoogle Scholar
• Chaiworapongsa T, Yoshimatsu J, Espinoza J, Kim Y M, Berman S, Edwin S, Yoon B H, Romero R. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002; 11: 362–367
   PubMedGoogle Scholar
• Erez O, Romero R, Hoppensteadt D, Than N G, Fareed J, Mazaki-Tovi S, Espinoza J, Chaiworapongsa T, Kim S S, Yoon B H, et al. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. Reprod Sci A 2007; 182
   Google Scholar
• Dorner T, Hoppe B, Salama A, Pruss A, Kiesewetter H. Antibodies against protein Z and fetal loss: current perspectives. Clin Exp Med 2005; 5: 50–54
   PubMed Web of Science ®Google Scholar
• Nordenvall M, Sandstedt B. Placental villitis and intrauterine growth retardation in a Swedish population. APMIS 1990; 98: 19–24
   PubMed Web of Science ®Google Scholar
• Becroft D M, Thompson J M, Mitchell E A. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 2005; 192: 264–271
   PubMed Web of Science ®Google Scholar
• Katzman P J, Genest D R. Maternal floor infarction and massive perivillous fibrin deposition: histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002; 5: 159–164
   PubMed Web of Science ®Google Scholar
• Laurini R, Laurin J, Marsal K. Placental histology and fetal blood flow in intrauterine growth retardation. Acta Obstet Gynecol Scand 1994; 73: 529–534
   PubMed Web of Science ®Google Scholar
• Althabe O, Labarrere C, Telenta M. Maternal vascular lesions in placentae of small-for-gestational-age infants. Placenta 1985; 6: 265–276
   PubMed Web of Science ®Google Scholar
• Altshuler G, Russell P, Ermocilla R. The placental pathology of small-for-gestational age infants. Am J Obstet Gynecol 1975; 121: 351–359
   PubMed Web of Science ®Google Scholar
• Becroft D M, Thompson J M, Mitchell E A. Placental infarcts, intervillous fibrin plaques, and intervillous thrombi: incidences, co-occurrences, and epidemiological associations. Pediatr Dev Pathol 2004; 7: 26–34
   PubMed Web of Science ®Google Scholar